-
J22352
- names:
J22352
- CAS号:
2252395-44-9
MDL Number: - MF(分子式): C24H21N3O4 MW(分子量): 415.44
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM002472-10mg | 10mg | 99.73% | ¥ 2565.00 | ¥ 2565.00 | 2-3天 | ¥ 0.00 | ||
| YZM002472-5mg | 5mg | 99.73% | ¥ 1560.00 | ¥ 1560.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 2252395-44-9 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C24H21N3O4 |
| 分子量 Molecular Weight | 415.44 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度125 mg/mL(300.89 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
J22352(CAS:2252395-44-9)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | J22352 是一种有效的具有类似靶向嵌合体蛋白水解 (PROTAC) 特性、高度选择性HDAC6抑制剂,其IC50值为 4.7 nM,J22352 通过抑制胶质母细胞瘤自噬、诱发抗肿瘤免疫反应来促进 HDAC6 降解和诱导抗癌效果,并通过降低 PD-L1 的免疫抑制活性,使宿主抗肿瘤活性恢复 |
| Introduction | J22352 is a PROTAC (proteolysisargeting chimeras)ike and highly selectiveHDAC6inhibitor with anIC50value of 4.7 nM. J22352 promotes HDAC6 degradation and induces anticancer effects by inhibiting autophagy and eliciting the antitumor immune response in glioblastoma cancers, and leading to the restoration of host antitumor activity by reducing the immunosuppressive activity of PD1. |
| Application1 | |
| Application2 | |
| Application3 |
J22352 是一种有效的具有类似靶向嵌合体蛋白水解 (PROTAC) 特性、高度选择性HDAC6抑制剂,其IC50值为 4.7 nM,J22352 通过抑制胶质母细胞瘤自噬、诱发抗肿瘤免疫反应来促进 HDAC6 降解和诱导抗癌效果,并通过降低 PD-L1 的免疫抑制活性,使宿主抗肿瘤活性恢复。J22352 is a PROTAC (proteolysis-targeting chimeras)-like and highly selectiveHDAC6inhibitor with anIC50value of 4.7 nM. J22352 promotes HDAC6 degradation and induces anticancer effects by inhibiting autophagy and eliciting the antitumor immune response in glioblastoma cancers, and leading to the restoration of host antitumor activity by reducing the immunosuppressive activity of PD-L1[1].
【1】.Liu JR, et al. High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma. Biochem Pharmacol. 2019 May; 163:458-471.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


